---
title: "Qianhong Bio-pharma released its 2024 annual performance, with a net profit attributable to the parent company of 356 million yuan, an increase of 95.77%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236550139.md"
description: "Qianhong Bio-pharma released its 2024 annual report, with operating revenue of 1.526 billion yuan, a year-on-year decrease of 15.88%; net profit attributable to shareholders of the parent company was 356 million yuan, a year-on-year increase of 95.77%; net profit excluding non-recurring gains and losses was 269 million yuan, a year-on-year increase of 87.48%. The basic earnings per share were 0.28 yuan, and it plans to distribute a cash dividend of 1.2 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-18T09:13:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236550139.md)
  - [en](https://longbridge.com/en/news/236550139.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236550139.md)
generator: "portal-rs"
---

# Qianhong Bio-pharma released its 2024 annual performance, with a net profit attributable to the parent company of 356 million yuan, an increase of 95.77%

According to the Zhitong Finance APP, Qianhong Bio-pharma (002550.SZ) released its annual report for 2024, showing an operating income of 1.526 billion yuan, a year-on-year decrease of 15.88%. The net profit attributable to shareholders of the listed company was 356 million yuan, a year-on-year increase of 95.77%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 269 million yuan, a year-on-year increase of 87.48%. The basic earnings per share were 0.28 yuan. In addition, it plans to distribute a cash dividend of 1.2 yuan (tax included) for every 10 shares to all shareholders

### Related Stocks

- [002550.CN](https://longbridge.com/en/quote/002550.CN.md)

## Related News & Research

- [Top Economist Slams Trump’s Venezuela Oil Deal ‘Theft’ — ‘Toppled Their Leader’ and ‘Had Him Sign Over Billions’](https://longbridge.com/en/news/298310697.md)
- [Saudi says no danger after Khamis Mushait alert amid clashes with Houthis](https://longbridge.com/en/news/298540011.md)
- [US Plains HRW Wheat-Basis steady as futures ease](https://longbridge.com/en/news/298510561.md)
- [Climeworks says upgraded Mammoth units more than double CO₂ capture performance](https://longbridge.com/en/news/298546691.md)
- [Kelun-Biotech partner Windward Bio starts Phase 3 POLARIS-1 asthma trial of SKB378/WIN378](https://longbridge.com/en/news/298315933.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**